We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
-3.76%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$302M
AUM Growth
-$29.4M
(-8.9%)
Cap. Flow
-$60.3M
Cap. Flow
% of AUM
-19.96%
Top 10 Holdings %
Top 10 Hldgs %
56.17%
Holding
86
New
16
Increased
11
Reduced
16
Closed
20
Avg Time Held Equity + Options
3
quarters
Top 10 Avg Time Held Equity + Options
0.9
quarters
Top 20 Avg Time Held Equity + Options
1.8
quarters
Avg Time Held Equity only
3.2
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$13.5M |
| 2 |
Sanofi
SNY
|
+$10.9M |
| 3 |
Inogen
INGN
|
+$9.8M |
| 4 |
Varex Imaging
VREX
|
+$8.02M |
| 5 |
Medpace
MEDP
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$17.3M |
| 2 |
SPDR Gold Trust
GLD
|
+$15.4M |
| 3 |
Cigna
CI
|
+$12.5M |
| 4 |
Herbalife
HLF
|
+$9.88M |
| 5 |
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$7.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.21% |
| 2 | Miscellaneous | 18.84% |
| 3 | Financials | 7.52% |
| 4 | Industrials | 0.43% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $34.7M | 11.48% |
+133,000
| New | +$31.6M |
2022 Q1
0 quarters
|
|
|
MSAC
2
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $22.7M | 7.52% |
2,323,000
| – | – |
2021 Q4
1 quarter
|
|
|
3
Cigna
CI
$74.7B
| $16.3M | 5.38% |
67,830
-53,500
| -44% | -$12.5M |
2020 Q3
6 quarters
|
|
4
Merck
MRK
$350B
| $16M | 5.3% |
195,160
-38,501
| -16% | -$3.04M |
2021 Q3
2 quarters
|
|
|
5
Sanofi
SNY
$93.7B
| $15.4M | 5.1% |
300,000
+211,751
| +240% | +$10.9M |
2021 Q4
1 quarter
|
|
|
6
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $15.3M | 5.05% |
+58,500
| New | +$13.9M |
2022 Q1
0 quarters
|
|
|
7
Labcorp
LH
$25.4B
| $13M | 4.3% |
+57,418
| New | +$13.5M |
2022 Q1
0 quarters
|
|
|
8
Inogen
INGN
$168M
| $13M | 4.29% |
400,086
+311,795
| +353% | +$9.8M |
2021 Q4
1 quarter
|
|
9
Cencora
COR
$63B
| $12.9M | 4.26% |
83,271
-14,169
| -15% | -$2.01M |
2021 Q4
1 quarter
|
|
10
McKesson
MCK
$112B
| $10.6M | 3.49% |
34,501
-22,555
| -40% | -$6.13M |
2019 Q3
10 quarters
|
|
11
United Therapeutics
UTHR
$23.3B
| $9.91M | 3.28% |
55,262
+2,069
| +4% | +$394K |
2018 Q4
13 quarters
|
|
|
12
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.9B
| $9.1M | 3.01% |
146,696
-114,681
| -44% | -$7.02M |
2021 Q3
2 quarters
|
|
13
Centene
CNC
$34B
| $8.15M | 2.69% |
96,762
-29,017
| -23% | -$2.38M |
2021 Q1
4 quarters
|
|
|
14
Varex Imaging
VREX
$784M
| $6.72M | 2.22% |
+315,486
| New | +$8.02M |
2022 Q1
0 quarters
|
|
15
Ionis Pharmaceuticals
IONS
$7.04B
| $6.5M | 2.15% |
175,568
-146,998
| -46% | -$4.81M |
2021 Q4
1 quarter
|
|
|
NTUS
16
DELISTED
Natus Medical Inc
NTUS
| $5.03M | 1.67% |
191,564
+83,869
| +78% | +$2.05M |
2021 Q3
2 quarters
|
|
|
VAPO
17
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.91M | 1.62% |
44,126
+21,624
| +96% | +$2.7M |
2021 Q4
1 quarter
|
|
|
18
Medpace
MEDP
$17B
| $4.65M | 1.54% |
+28,400
| New | +$4.68M |
2022 Q1
0 quarters
|
|
19
Curis
CRIS
$1.49M
| $4.56M | 1.51% |
4,789
-4,878
| -50% | -$6.23M |
2020 Q2
7 quarters
|
|
|
ALBO
20
DELISTED
Albireo Pharma Inc
ALBO
| $4.31M | 1.43% |
144,546
-69,367
| -32% | -$2.03M |
2020 Q3
6 quarters
|
|
21
PUT
Nektar Therapeutics
NKTR
$1.29B
| $3.74M | 1.24% |
+46,247
| New | +$6.84M |
2022 Q1
0 quarters
|
|
22
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.65M | 1.21% |
+40,210
| New | +$3.29M |
2022 Q1
0 quarters
|
|
23
Mirum Pharmaceuticals
MIRM
$5.17B
| $3.55M | 1.17% |
161,285
-109,029
| -40% | -$2.22M |
2020 Q4
5 quarters
|
|
24
Xenon Pharmaceuticals
XENE
$3.33B
| $3.23M | 1.07% |
+105,756
| New | +$3.17M |
2022 Q1
0 quarters
|
|
|
RCOR
25
DELISTED
Renovacor, Inc.
RCOR
| $3.12M | 1.03% |
735,908
| – | – |
2021 Q1
4 quarters
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Sio Capital Management held 86 positions worth $302M, down 8.9% from $332M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Sio Capital Management withdrew a net $60.3M in Q1 2022, closing 20 positions and reducing 16 holdings. Its most notable exit was Cardinal Health, an estimated $17.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 83% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Sio Capital Management opened a new position in Labcorp worth $13M.
- Sio Capital Management's largest Q1 2022 buy was Labcorp: 57,418 shares worth $13M.
- Sio Capital Management added most to Sanofi in Q1 2022, an estimated $10.9M increase.
- Sio Capital Management's biggest Q1 2022 reduction was Cigna, cutting an estimated $12.5M.
- Sio Capital Management fully exited Cardinal Health in Q1 2022, selling an estimated $17.3M.
- Sio Capital Management's ten largest holdings make up 56% of its $302M portfolio in Q1 2022.
- Sio Capital Management opened 16 new positions and closed 20 in Q1 2022.
- Sio Capital Management's portfolio value fell 8.9% quarter-over-quarter to $302M.
Based on Sio Capital Management's 13F filing for Q1 2022, filed 16 May 2022.